Loading...
Please wait, while we are loading the content...
Stage III Non-small Cell Lung Cancer
| Content Provider | Scilit |
|---|---|
| Author | Rusch, Valerie W. |
| Copyright Year | 2016 |
| Description | More than 20% of non-small cell lung cancers (NSCLCs) are classified as stage III disease at diagnosis because they are locoregionally advanced tumors. Local therapy alone (surgery or radiation) leads to poor overall survival in stage III NSCLC because most of the patients with NSCLC die of distant metastases. Therefore, during the past 20 years, studies have focused on developing effective chemotherapy regimens that can be combined with local therapies (surgery and/or radiation). The role of surgery has been extensively evaluated and the selection criteria for resection defined. |
| Related Links | http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0036-1592112.pdf |
| Ending Page | 735 |
| Page Count | 9 |
| Starting Page | 727 |
| ISSN | 10693424 |
| e-ISSN | 10989048 |
| DOI | 10.1055/s-0036-1592112 |
| Journal | Seminars in Respiratory and Critical Care Medicine |
| Issue Number | 05 |
| Volume Number | 37 |
| Language | English |
| Publisher | Georg Thieme Verlag KG |
| Publisher Date | 2016-10-12 |
| Access Restriction | Open |
| Subject Keyword | Journal: Seminars in Respiratory and Critical Care Medicine Radiology, Nuclear Medicine and Imaging Lung Cancer Multimodality Therapy Iiia (n2) |
| Content Type | Text |
| Resource Type | Article |
| Subject | Pulmonary and Respiratory Medicine Critical Care and Intensive Care Medicine |
